AI assistant
Edgewise Therapeutics, Inc. — Director's Dealing 2021
Mar 26, 2021
31829_dirs_2021-03-25_98849686-1694-475e-a8cb-8352355507b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Edgewise Therapeutics, Inc. (EWTX)
CIK: 0001710072
Period of Report: 2021-03-25
Reporting Person: Russell Alan J (Director, Chief Scientific Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 264100 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.18 | 2032-06-27 | Common Stock (1531780) | Direct | |
| Stock Option (Right to Buy) | $0.18 | 2027-08-08 | Common Stock (147585) | Direct | |
| Stock Option (Right to Buy) | $0.45 | 2028-08-30 | Common Stock (155352) | Direct | |
| Stock Option (Right to Buy) | $0.64 | 2029-11-14 | Common Stock (227332) | Direct | |
| Stock Option (Right to Buy) | $0.71 | 2030-09-01 | Common Stock (190137) | Direct | |
| Stock Option (Right to Buy) | $1.93 | 2030-12-15 | Common Stock (475183) | Direct |
Footnotes
F1: 1/48th of the shares subject to the option became vested and exercisable on July 27, 2017 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.
F2: 1/4th of the shares subject to the option became vested and exercisable on July 27, 2018 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.
F3: 1/48th of the shares subject to the option became vested and exercisable on September 10, 2018 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.
F4: 1/48th of the shares subject to the option became vested and exercisable on November 16, 2019 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.
F5: 1/48th of the shares subject to the option became vested and exercisable on October 2, 2020 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.
F6: 1/48th of the shares subject to the option became vested and exercisable on January 30, 2021 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.